The US Food and Drug Administration (FDA) recently approved linagliptin (Tradjenta) for improving blood glucose levels in adults with type 2 diabetes, either as a stand-alone or in combination with other therapies.
This DPP-4 inhibitor was developed by Eli Lilly and Boehringer Ingelheim and will be marketed under the brand name of Tradjenta.
Diabetes Type 1, Type 2 - Causes Symptoms Diagnosis and Treatment FAQs
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, symptoms, diagnosis, treatment, facts and a glossary on diabetes.
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, symptoms, diagnosis, treatment, facts and a glossary on diabetes.
Like other DPP-4 inhibitors, linagliptin can be taken in combination with other diabetes drugs, such as metformin. However, its use with insulin has yet to be tested.
Mary Parks, MD, Director of the FDA's Division of Metabolism and Endocrinology Products says in a recent news release, "This approval provides another treatment option for the millions of people with type 2 diabetes. It is equally effective when used alone or when added to existing treatment regimens."
Quiz on Diabetes
Diabetes has replaced every other condition to become the fastest growing lifestyle disease, globally. This disease also impacts children. Some people are more inclined to develop diabetes than others. Do you belong to the high- risk group? Spend 5 minutes to find out.
Diabetes has replaced every other condition to become the fastest growing lifestyle disease, globally. This disease also impacts children. Some people are more inclined to develop diabetes than others. Do you belong to the high- risk group? Spend 5 minutes to find out.
Clinicians are advised not to prescribe the drug in patients with type 1 diabetes or those who have diabetic ketoacidosis. The most common side effects of linagliptin are upper respiratory infection (URI), sore throat, stuffy or runny nose, headache, muscle pain.
Advertisement
Top Ten Facts About Diabetes
Diabetes or diabetes mellitus, is an endocrine and metabolic disorder characterized by high blood sugar levels (hyperglycemia) over a prolonged period of time.
Diabetes or diabetes mellitus, is an endocrine and metabolic disorder characterized by high blood sugar levels (hyperglycemia) over a prolonged period of time.
Reference Article:
Advertisement
Two-in-one Diabetic Drug Approved by FDA
The Federal Drug Administration of U.S has approved Janumet, produced by Merck & Co., Inc.
The Federal Drug Administration of U.S has approved Janumet, produced by Merck & Co., Inc.
Source-Medindia
